Virtus Fund Advisers’s Avanos Medical AVNS Stock Holding History

Virtus Fund Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-223	Closed	-$7K	–	545
2015 Q4	$7K	Hold	223	–	–	﹤0.01%	710
2015 Q3	$6K	Hold	223	–	–	﹤0.01%	730
2015 Q2	$9K	Sell	223 -580	-72%	-$26K	﹤0.01%	686
2015 Q1	$40K	Sell	803 -95	-11%	-$4.4K	﹤0.01%	767
2014 Q4	$41K	Buy	+898	New	+$35.3K	﹤0.01%	823

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Virtus Fund Advisers's AVNS Position: Q1 2016 in Review

Virtus Fund Advisers sold out of Avanos Medical (AVNS) in Q1 2016, closing a stake of 223 shares — an estimated $7K sold.

Virtus Fund Advisers first reported a position in AVNS in Q4 2014 and held it in 5 quarters. The position peaked at $41K in Q4 2014. 333 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

Virtus Fund Advisers reported no remaining Avanos Medical position as of Q1 2016 after selling out during the quarter.
Virtus Fund Advisers sold 223 Avanos Medical shares in Q1 2016, an estimated $7K.
Virtus Fund Advisers first reported a position in Avanos Medical in Q4 2014 and held it in 5 quarters.
Virtus Fund Advisers's Avanos Medical position peaked at $41K in Q4 2014.
333 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Virtus Fund Advisers's 13F filing for Q1 2016, filed 11 May 2016.